← Eichor
Study identifier: NCT07029984 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Baylor Continence Scale Validity in Anorectal Malformation

Condition: Anorectal Malformations  ·  Sponsor: Izmir Bakircay University

PhaseN/A
Planned participants230
Who can joinAll sexes, 6 Years to 18 Years
Healthy volunteersNo

About this study

The aim of this study is to evaluate the validity and reliability of the Baylor Continence Scale in Turkish-speaking children diagnosed with anorectal malformations. The scale is used to assess continence levels, helping healthcare providers make informed decisions regarding treatment and follow-up. The study includes a sample of children with confirmed anorectal malformations, and data collection consists of language adaptation, statistical validation, and reliability testing. Results will contribute to the standardization of continence assessment in Turkish clinical settings, ensuring accurate evaluations for pediatric patients.

This description comes directly from the study's public registry record.

Talk to the study team

Ayşe Kayalı Vatansever, Assistant Professor, PhD  ·  +905529382360  ·  ayse.vatansever@bakircay.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Ege University Department of Pediatric Surgery and Bakırçay University Physical Therapy and Rehabilitation Application and Research CenterIzmir, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07029984